PubMed

Optimizing insulin secretagogue therapy in patients with type 2 diabetes: a randomized double-blind study with repaglinide.

Schmitz O, Lund S, Andersen PH, Jønler M, Pørksen N.

Diabetes Care. 2002 Feb;25(2):342-6.PMID: 11815507 [PubMed - indexed for MEDLINE]Related articlesFree article

Repaglinide--prandial glucose regulator: a new class of oral antidiabetic drugs.

Owens DR.

Diabet Med. 1998;15 Suppl 4:S28-36. Review.PMID: 9868989 [PubMed - indexed for MEDLINE]Related articles

Flexible meal-related dosing with repaglinide facilitates glycemic control in therapy-naive type 2 diabetes.

Moses RG, Gomis R, Frandsen KB, Schlienger JL, Dedov I.

Diabetes Care. 2001 Jan;24(1):11-5.PMID: 11194214 [PubMed - indexed for MEDLINE]Related articlesFree article

Repaglinide improves blood glucose control in sulphonylurea-naive type 2 diabetes.

Van Gaal LF, Van Acker KL, De Leeuw IH.

Diabetes Res Clin Pract. 2001 Sep;53(3):141-8.PMID: 11483229 [PubMed - indexed for MEDLINE]Related articles

A double-blind randomized comparison of meal-related glycemic control by repaglinide and glyburide in well-controlled type 2 diabetic patients.

Damsbo P, Clauson P, Marbury TC, Windfeld K.

Diabetes Care. 1999 May;22(5):789-94.PMID: 10332683 [PubMed - indexed for MEDLINE]Related articlesFree article

Pre-prandial vs. post-prandial capillary glucose measurements as targets for repaglinide dose titration in people with diet-treated or metformin-treated Type 2 diabetes: a randomized controlled clinical trial.

Gerstein HC, Garon J, Joyce C, Rolfe A, Walter CM.

Diabet Med. 2004 Nov;21(11):1200-3.PMID: 15498086 [PubMed - indexed for MEDLINE]Related articles

Increased prandial insulin secretion after administration of a single preprandial oral dose of repaglinide in patients with type 2 diabetes.

Owens DR, Luzio SD, Ismail I, Bayer T.

Diabetes Care. 2000 Apr;23(4):518-23.PMID: 10857945 [PubMed - indexed for MEDLINE]Related articlesFree article

Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: a one-year, randomized, double-blind assessment of metabolic parameters and cardiovascular risk factors.

Derosa G, Mugellini A, Ciccarelli L, Crescenzi G, Fogari R.

Clin Ther. 2003 Feb;25(2):472-84.PMID: 12749508 [PubMed - indexed for MEDLINE]Related articles

Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.

Lund SS, Tarnow L, Frandsen M, Smidt UM, Pedersen O, Parving HH, Vaag AA.

Eur J Endocrinol. 2008 Jan;158(1):35-46.PMID: 18166815 [PubMed - indexed for MEDLINE]Related articlesFree article

Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.

Tîrgovişte CI, Străchinariu R, Farcaşiu E, Milicevic Z, Teodorescu G.

Rom J Intern Med. 2003;41(2):153-62.PMID: 15526500 [PubMed - indexed for MEDLINE]Related articles

Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

Clin Ther. 2008 Aug;30(8):1448-60. Erratum in: Clin Ther. 2008 Oct;30(10):1937. PMID: 18803987 [PubMed - indexed for MEDLINE]Related articles

A randomized placebo-controlled trial of repaglinide in the treatment of type 2 diabetes.

Goldberg RB, Einhorn D, Lucas CP, Rendell MS, Damsbo P, Huang WC, Strange P, Brodows RG.

Diabetes Care. 1998 Nov;21(11):1897-903.PMID: 9802740 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of the effects of three insulinotropic drugs on plasma insulin levels after a standard meal.

Cozma LS, Luzio SD, Dunseath GJ, Langendorg KW, Pieber T, Owens DR.

Diabetes Care. 2002 Aug;25(8):1271-6.PMID: 12145220 [PubMed - indexed for MEDLINE]Related articlesFree article

Beta-cell response during a meal test: a comparative study of incremental doses of repaglinide in type 2 diabetic patients.

Cozma LS, Luzio SD, Dunseath GJ, Underwood PM, Owens DR.

Diabetes Care. 2005 May;28(5):1001-7.PMID: 15855557 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety of combination therapy: repaglinide plus metformin versus nateglinide plus metformin.

Raskin P, Klaff L, McGill J, South SA, Hollander P, Khutoryansky N, Hale PM; Repaglinide vs. Nateglinide Metformin Combination Study Group.

Diabetes Care. 2003 Jul;26(7):2063-8. Erratum in: Diabetes Care. 2003 Sep;26(9):2708. PMID: 12832314 [PubMed - indexed for MEDLINE]Related articlesFree article

Repaglinide versus glyburide: a one-year comparison trial.

Marbury T, Huang WC, Strange P, Lebovitz H.

Diabetes Res Clin Pract. 1999 Mar;43(3):155-66.PMID: 10369424 [PubMed - indexed for MEDLINE]Related articles

Review of prandial glucose regulation with repaglinide: a solution to the problem of hypoglycaemia in the treatment of Type 2 diabetes?

Nattrass M, Lauritzen T.

Int J Obes Relat Metab Disord. 2000 Sep;24 Suppl 3:S21-31. Review.PMID: 11063281 [PubMed - indexed for MEDLINE]Related articles

Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application.

Rosak C, Hofmann U, Paulwitz O.

Diabetes Nutr Metab. 2004 Jun;17(3):137-42.PMID: 15334790 [PubMed - indexed for MEDLINE]Related articles

Improvement of insulin sensitivity and beta-cell function by nateglinide and repaglinide in type 2 diabetic patients - a randomized controlled double-blind and double-dummy multicentre clinical trial.

Li J, Tian H, Li Q, Wang N, Wu T, Liu Y, Ni Z, Yu H, Liang J, Luo R, Li Y, Huang L.

Diabetes Obes Metab. 2007 Jul;9(4):558-65.PMID: 17587398 [PubMed - indexed for MEDLINE]Related articles